Gene: NFIX
Official Full Name: nuclear factor I Xprovided by HGNC
Gene Summary: The protein encoded by this gene is a transcription factor that binds the palindromic sequence 5'-TTGGCNNNNNGCCAA-3 in viral and cellular promoters. The encoded protein can also stimulate adenovirus replication in vitro. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36378 | NFIX Knockout cell line (HeLa) | Human | NFIX | 1:3~1:6 | Negative | Online Inquiry |
KO36379 | NFIX Knockout cell line (HCT 116) | Human | NFIX | 1:2~1:4 | Negative | Online Inquiry |
KO36380 | NFIX Knockout cell line (HEK293) | Human | NFIX | 1:3~1:6 | Negative | Online Inquiry |
KO36381 | NFIX Knockout cell line (A549) | Human | NFIX | 1:3~1:4 | Negative | Online Inquiry |
NFIX Gene Knockout Cell Lines are advanced biological tools designed to facilitate the study of the NFIX gene, a vital component in various cellular processes and development pathways. These cell lines have been engineered using CRISPR/Cas9 gene-editing technology to create precise deletions of the NFIX gene, allowing researchers to investigate the role of this gene in gene regulation, cellular differentiation, and potential implications in diseases such as cancer and neurological disorders.
The key function of these knockout cell lines lies in their ability to eliminate NFIX expression, enabling scientists to observe phenotypic changes and cellular behavior under controlled conditions. By modulating NFIX activity, researchers can uncover its underlying mechanisms and interactions with other molecular pathways, thereby gaining insight into the gene's contribution to normal physiology and disease pathology.
In research and clinical contexts, NFIX Gene Knockout Cell Lines serve an essential role in drug discovery processes, monogenic disease research, and the development of gene therapies. Their applications extend to functional genomics, where scientists can explore gene functions through high-throughput screening of small molecules, RNA interference, and other therapeutic interventions.
What sets NFIX Gene Knockout Cell Lines apart from conventional models is their precision and reliability. The CRISPR technology utilized ensures specific targeting of the NFIX gene, minimizing off-target effects and enhancing reproducibility in experiments. Furthermore, these cell lines can be cultured easily and are adaptable for various assays, making them invaluable for both basic and translational research.
Researchers and clinicians alike will find value in NFIX Gene Knockout Cell Lines as they represent a cutting-edge resource for elucidating gene function and advancing therapeutic strategies. The cost-effectiveness and time-saving nature of these models facilitate more efficient research outcomes, enabling users to achieve significant scientific advancements.
Our company specializes in the development of high-quality biological products, leveraging state-of-the-art gene-editing technologies. With a commitment to excellence and innovation, we provide tools designed to empower researchers and clinicians in their quest for knowledge and therapeutic breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.